Opinion Article, J Pharm Sci Emerg Drugs Vol: 11 Issue: 1

Minimizing the Risk of Adverse Drug Reactions in Pregnant Women: Best Practices and Guidelines

Giridhar Sharma^*

Department of Physiology, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India

*Corresponding Author: Giridhar Sharma
Department of Physiology, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
E-mail: sgiridhar@gmail.com

Received date: 22 January, 2023, Manuscript No. JPSED-23-92359;

Editor assigned date: 24 January, 2023, Pre QC. JPSED-23-92359(PQ);

Reviewed date: 14 February, 2023, QC No. JPSED-23-92359;

Revised date: 21 February, 2023, Manuscript No. JPSED-23-92359(R);

Published date: 28 February, 2023, DOI: 10.4172/2324-8955.1000121.

Citation: Sharma G (2023) Minimizing the Risk of Adverse Drug Reactions in Pregnant Women: Best Practices and Guidelines. J Pharm Sci Emerg Drugs 11:1.

Description

Adverse drug reactions in pregnant women can have serious consequences for both the mother and the developing fetus. Pregnancy is a complex physiological state that can alter the way drugs are absorbed, distributed, metabolized, and eliminated from the body, leading to potential toxicity or ineffective treatment [1].

Additionally, some drugs have been linked to developmental defects, fetal growth restriction, and increased risk of miscarriage, stillbirth, or preterm labor. Therefore, it is crucial to carefully weigh the benefits and risks of any medication before prescribing it to a pregnant woman [2].

Healthcare providers should follow established guidelines and consult with a perinatal specialist or a teratology information service to make informed decisions about drug therapy during pregnancy. Pregnant women should also inform their healthcare providers about any prescription or over-the-counter medications, herbal supplements, or recreational drugs they are taking to minimize the risk of adverse drug reactions [3].

Impact of drug reactions on pregnant women

Birth defects: Certain medications can increase the risk of birth defects, such as neural tube defects, heart defects, cleft lip or palate, and limb abnormalities.

Miscarriage: Adverse drug reactions can lead to a higher risk of miscarriage, especially during the first trimester of pregnancy.

Preterm labor: Some medications can cause preterm labor, which can increase the risk of respiratory distress syndrome, bleeding in the brain, and other complications for the newborn.

Fetal growth restriction: Certain drugs can restrict fetal growth, which can lead to low birth weight and other health problems for the newborn.

Maternal health problems: Adverse drug reactions can also lead to health problems for the mother, such as kidney or liver damage, bleeding disorders, or hypertension [4].

Treatments methods for adverse drug reactions in pregnant women

Discontinuing the medication: If the medication causing an adverse reaction, the healthcare provider may recommend discontinuing the medication, especially if the risks outweigh the benefits.

Switching to a safer medication: if the medication necessary for the mother's health, the healthcare provider may recommend switching to a safer medication that has a lower risk of adverse effects on the fetus.

Supportive care: In some cases, supportive care may be necessary to manage the symptoms of the adverse drug reaction. For example, if a medication is causing nausea or vomiting, the healthcare provider may recommend anti-nausea medication or hydration therapy.

Monitoring: Pregnant women who have had an adverse drug reaction may need to be closely monitored for any potential complications, such as preterm labor or fetal distress.

Consultation with specialists: Healthcare providers may consult with specialists, such as maternal-fetal medicine specialists or teratology information services, to help manage and treat adverse drug reactions in pregnant women.

Conclusion

It is important to note that not all adverse drug reactions result in severe consequences, and the risks and benefits of medication use during pregnancy should always be carefully evaluated on a case-bycase basis. Pregnant women and healthcare providers should work together to make informed decisions about medication use during pregnancy and to closely monitor for any potential adverse reactions. It is important for pregnant women to inform their healthcare providers of any medications, supplements, or herbal remedies they are taking to help minimize the risk of adverse drug reactions. Healthcare providers should carefully weigh the risks and benefits of medication use during pregnancy and closely monitor pregnant women for any potential adverse effects.

References

1. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, et al (2006) Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr 41:53-58.

   [Crossref][Google Scholar][Indexed]

2. Mocroft A, Youle M, Moore A, Sabin CA, Madge S, et al (2001) Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. Aids 15:185-194.

   [Crossref][Google Scholar][Indexed]

3. Ford N, Calmy A, Andrieux-Meyer I, Hargreaves S, Mills EJ, et al (2013) Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. Aids 27:1135-43.

   [Crossref][Google Scholar][Indexed]

4. Bera E, Mia R (2012) Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis. S Afr Med J 102:855-859.

   [Crossref][Google Scholar][Indexed]